Skip to main content
Clinical Trials/NCT06959992
NCT06959992RecruitingNot Applicable

Evaluating the Efficacy of Virtual Support Groups Fostering Resilience for Gender Diverse People: a Randomized Clinical Trial in the Metaverse

University of Bucharest2 sites in 1 country123 target enrollmentStarted: September 1, 2025Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
123
Locations
2
Primary Endpoint
Gender-affirmation

Study Overview

Brief Summary

The goal of this clinical trial is to test the effectiveness of conducting a support group in the Metaverse designed to develop and/or improve resilience in gender diverse people. By exploring the impact of different social challenges in a virtual environment, the main question it aims to answer is whether this approach on conducting support group sessions with gender diverse people will strengthen their resilience and associated abilities (self-compassion) compared to a control group and a waitlist.

Detailed Description

The gender diverse population is inclined toward online expression as a way to connect with the community and to explore ways of handling stigma from harsh environments that they live in. The potential beneficial effects of conducting a support group to build resilience and self-compassion, with members from the gender minority community in a virtual environment, allowing the expression of gender identity through avatar customization and social interaction are being tested in the form of a Randomized Clinical Trial (RCT). There are three conditions: the virtual group (enrolling in a Metaverse platform with immersive features), the standard group (enrolling in an online forum platform) and the waitlist group.

The study is a between-subjects design with three arms and involves comparisons between pre-intervention, post-intervention and follow-up between: (a) Initial psychological states of the participants, (b) Mid-session, (c) After the support group sessions and (d) At follow-up (3 months). Participants will be randomly allocated to one of the three experimental arms.

For small-medium effect sizes assumed (f = 0.25), 3 groups and 4 measurements in time (pre- and post-intervention and one follow-up), a repeated measure analyzing between-within factors a minimum of 123 participants (total sample size) are needed. A target of 135 people (45 per group) has been set to allow for potential dropouts (~10%). Depending on recruitment feasibility and dropout rates throughout the study, this number may be increased.

The group sessions should be re-run several times as the chosen Metaverse platform and the general recommendations for conducting support groups limit the number of participants to 7-8 people/group.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Transgender and nonbinary individuals with a stable gender-identity or questioning

Exclusion Criteria

  • Presence of acute psychiatric instability (e.g., acute psychotic symptomatology or acute suicide risk)
  • Not being part of the transgender population
  • Younger than 18

Arms & Interventions

Waitlist

No Intervention

Control

Metaverse group

Experimental

Immersive online environment

Intervention: Metaverse group (Behavioral)

Standard asynchronous online group

Active Comparator

Online environment

Intervention: Online asynchronously (Behavioral)

Outcomes

Primary Outcomes

Gender-affirmation

Time Frame: Up to 5 months

Assessing changes in levels of comfort and satisfaction related to gender identity with The Psychological Gender Affirmation Scale which contains 5 items, ranging from 1 - Not at all to 5 - Extremely. Higher scores indicate better outcomes.

Resilience

Time Frame: Up to 5 months

Assessing changes in resilient attitudes from a general perspective with the Brief Resilience Scale (6 items on a 5-point Likert response scale, ranging from 1 - Strongly disagree to 5 - Strongly agree) and from a specific view of gender minority resilience with the Gender Minority Stress and Resilience Measure. Only the resilience items will be selected from the 58-items scale (5 items for Community connectedness and 8 items for Pride). Responses range from 0 - Strongly disagree to 4 - Strongly agree. Higher scores indicate better outcomes.

Stress and mental health correlates

Time Frame: Up to 5 months

Assessing changes in perceived distal (Discrimination, Rejection and Victimization - 17 items) and proximal stress factors (Non-affirmation of gender identity, Internalized transphobia, Nondisclosure and Negative future expectations - 28 items) with the Gender Minority Stress and Resilience Measure (selecting only stress-related items) and in mental health symptoms with the Depression, Anxiety, Stress Scale (DASS), containing 21 items. Higher scores mean worse outcomes.

Coping mechanisms

Time Frame: Up to 5 months

Assessing changes in approached coping mechanisms with the Trans and Nonbinary Coping Measure containing 28 items and 6 subscales with both adaptive and maladaptive types of coping, on a 5-point Likert scale (1 - I do not do this to 5 - I almost always do this). Scoring significance depends on the nature of the coping mechanisms.

Self-compassion

Time Frame: Up to 5 months

Assessing changes in self-compassionate attitudes with the Short Form of the Self-Compassion Scale, containing 12 items on a 5-point Likert response scale ranging from 1 - Almost never to 5 - Almost always. Higher scores mean better outcomes.

Social support

Time Frame: Up to 5 months

Assessing changes in perceived social support with the Multidimensional Scale of Perceived Social Support, containing 12 items on a 7-point Likert response scale (ranging rom 1 - Very strongly disagree to 7 - Very strongly agree). Higher scores mean better outcomes.

Positive gender identity characteristics

Time Frame: Through study completion, an average of 3 months

Assessing changes in positive characteristics of gender identity with the Transgender Positive Identity Measure with 24 items with a 7-point Likert response scale (ranging from 1 - Strongly disagree to 7 - Strongly agree).

Secondary Outcomes

  • Mood changes(Through study completion, an average of 3 months)
  • Attitudes toward self(Up to 5 months)
  • Assertive attitude(Up to 5 months)
  • Self-efficacy(Up to 5 months)

Investigators

Sponsor
University of Bucharest
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Cezar Giosan

Associate Professor of Psychology

University of Bucharest

Study Sites (2)

Loading locations...

Similar Trials

Developing Resilience in Transgender and... | Clinical Trial